![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, December 21, 2010 7:59:23 AM
Is Sucanan an herbal remedy or a drug? If is an herbal remedy why do we need the FDA's approval? do we have to call it a drug or have it classified a drug in order to get Dr to recommend it to people?
Sucanon™ is a new herbally-based medication that helps the body improve the use of its own insulin, the hormone that controls blood sugar levels. The increased sensitivity to insulin leads to decreased blood sugar levels. Sucanon has been shown to reduce the symptoms of Type II Diabetes, including weight gain, fatigue, excess thirst and excess urination.
Sucanon™ has been tested on more than 7,000 people with no adverse effects. Sucanon™ helps to reduce the symptoms of fatigue, weakness, excess thirst, frequent urination and unwanted weight gain so often associated with Type II Diabetes.
Sucanon™ is produced in Canada, packaged in Mexico and is now available online. If you or your doctor would like more information about Sucanon™ , click above on about Sucanon™.
AND
Q. Is Sucanon a prescription product?
A. Sucanon has been approved for prescription sale in Peru and has been approved as an over-the-counter (non-prescription) product in Mexico, where it is widely sold.
Q. If I live in the U.S. or Canada, can my doctor prescribe Sucanon for me?
A. No regulatory application has been made yet in the United States so doctors cannot prescribed Sucanon. However, Type II diabetics can buy Sucanon for their own use and have it delivered to them from Mexico under the U.S. FDA’s “personal importation” guidelines. A similar program exists for Type II diabetics in Canada who wish to buy Sucanon for their own use.
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM